XL Batteries

Eterna Therapeutics, based in New York, NY, is a pioneering biotech company focused on unlocking the potential of cell engineering for curative and transformative therapies. With over 100 patents developed over the last 12 years, Eterna collaborates with life sciences companies in areas such as cell reprogramming, gene editing, and gene delivery using their proprietary mRNA technology. Specializing in rare diseases, autoimmune diseases, and oncology, Eterna not only licenses its extensive patent portfolio but also strives to develop therapeutic candidates. Recent announcements include the appointment of Peter Cicala to its board of directors and the induction of Sanjeev Luther as the new President and CEO. Generated from the website

Mirimus, Inc. is a Brooklyn-based biotech and preclinical contract research organization (CRO) recognized with an XPRIZE award, specializing in scalable solutions for the preclinical evaluation of novel therapeutic targets through advanced genetically engineered in vivo models. The company utilizes cutting-edge gene editing and RNA interference (RNAi) technologies to develop human models of disease, advancing research in human health. With a focus on providing high-quality animal and cell models for in vivo studies, Mirimus empowers researchers by designing custom translatable models featuring potent reversible gene silencing. Their innovative offerings include customizable RNAi and CRISPR Cas9 mouse and rat models, as well as clinically relevant 3D tissue cultures developed from induced pluripotent stem cells (iPSCs). Generated from the website

Lucerna is an innovative biotech company based in Brooklyn, NY, specializing in the development and commercialization of cutting-edge RNA-based research tools. Founded in 2010 by a team of scientists, Lucerna is dedicated to advancing scientific discovery by providing scientists with RNA-focused research reagents. Their flagship product, the Spinach technology, enables the visualization and study of RNA localization and movements under a microscope, revolutionizing the field of RNA research. With a strong focus on developing unique tools to address urgent problems in the RNA world, Lucerna is committed to accelerating biological research and drug discovery. Driven by a mission to be the market leader in RNA-based research reagents, Lucerna has made significant strides since its inception. Their product portfolio includes a range of proprietary fluorophores, high-throughput compatible assays, and custom fluorescent sensors that detect medically important RNAs with specificity and sensitivity. With a team of high-caliber scientists with extensive RNA biology and assay development backgrounds, Lucerna combines the rigor of an academic research institution with the innovative spirit of a biotechnology company, aiming to make a meaningful impact in the field of RNA research and contribute to the development of potential cures for RNA-related diseases.Generated from the website